Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
SCANIMALHEALTH ApS
APS
In liquidation
CVR 26208815
Mekuvej 9, 7171
Uldum
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2001 · 24 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
SCANIMALHEALTH ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (7)
ID
Ian David Page
Chief Executive Officer
Chief Executive Officer
2012 – 2017
GP
Gunnar Pedersen
Management
Management
2001 – 2010
JO
Jacob Ove Kornerup
Unofficial title
Unofficial title
2017 – 2018
JJ
Jan Jaap Korevaar
Management
Management
2012 – 2012
SD
Simon David Evans
Management
Management
2012 – 2012
OB
Oluf Bagge Hjortlund
Management
Management
2001 – 2001
ML
Martin Lemche
Management
Management
2012 – 2012
Board of directors
Non-executive oversight
Name
Role
Member since
Former (10)
ID
Ian David Page
Board of Directors
Board of Directors
2012 – 2017
GP
Gunnar Pedersen
Board of Directors
Board of Directors
2001 – 2010
JJ
Jan Jaap Korevaar
Board of Directors
Board of Directors
2012 – 2012
AL
Anni Lissi Pedersen
Board of Directors
Board of Directors
2001 – 2010
AB
Annette Bundgaard Bech
Board of Directors
Board of Directors
2001 – 2007
SD
Simon David Evans
Board of Directors
Board of Directors
2012 – 2012
AG
Anthony Gerard Griffin
Board of Directors
Board of Directors
2010 – 2017
ID
Ian David Page
Board of Directors
Board of Directors
2012 – 2012
AN
Anne-Francoise Nesmes
Board of Directors
Board of Directors
2013 – 2016
SD
Simon David Evans
Board of Directors
Board of Directors
2012 – 2012
Shareholders
As of last annual report
Eurovet Animal Health B.V — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Eurovet Animal Health B.V
Company
100%
100%
2010
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on SCANIMALHEALTH ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network